Free Research Report as Streamline Reported Better than Expected Result

LONDON, UK / ACCESSWIRE / January 10, 2018 / Active-Investors.com has just released a free earnings report on Streamline Health Solutions, Inc. (NASDAQ: STRM) (“Streamline”). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=STRM. The Company posted its financial results on December 12, 2017, for the third quarter fiscal 2017. Register today and get access to over 1,000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Streamline Health Solutions most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=STRM

Earnings Highlights and Summary

For three months ended October 31, 2017, Streamline’s revenues decreased 3% to $6.40 million from $6.64 million in Q3 FY16. The Company’s revenues surpassed analysts’ expectations of $6.27 million.

As on October 31, 2017, the Company’s backlog decreased 13.2% to $47.67 million from $54.92 million on October 31, 2016.

For the reported quarter, the Company’s earnings before interest, tax, depreciation, and amortization (EBITDA) was positive $1,050 compared to negative $459 in Q3 FY16. For the reported quarter, the Company’s adjusted EBITDA increased 564% to $1,514 from $228 in Q3 FY16. During Q3 FY17, Streamline’s adjusted EBITDA margin increased 2100 basis points to 24% of revenue from 3% of revenue in Q3 FY16.

For the reported quarter, the Company’s operating income was $296,456 compared to operating loss of $1.77 million in Q3 FY16.

During Q3 FY17, Streamline’s earnings before tax (EBT) was positive $6,096 compared to negative $1.93 million in the same period last year.

For the reported quarter, Streamline’s net income was $3,489 compared to net loss of $2.00 million in Q3 FY16. During Q3 FY17, the Company’s diluted EPS was $0 compared to negative $0.10 in the same period last year. Diluted EPS surpassed analysts’ expectations of negative $0.06.

Streamline Health Solutions’ Segment Details

Systems – During Q3 FY17, the Systems segment’s revenue increased 10.9% to $348,526 from $314,218 in the same period last year. For the reported quarter, the segment’s gross profit was negative $85,612 compared to negative $348,930 in Q3 FY16.

Professional services – During Q3 FY17, the Professional services segment’s revenue increased 27.1% to $801,771 from $630,961 in the same period last year. For the reported quarter, the segment’s gross profit was positive $245,956 compared to negative $92,397 in Q3 FY16.

Audit Services – During Q3 FY17, the Audit Services segment’s revenue increased 19.5% to $280,025 from $234,347 in the same period last year. For the reported quarter, the segment’s gross profit was negative $124,255 compared to negative $361,228 in Q3 FY16.

Maintenance and support – During Q3 FY17, the Maintenance and support segment’s revenue decreased 13.3% to $3.25 million from $3.75 million in the same period last year. For the reported quarter, the segment’s gross profit decreased 12.8% to $2.58 million from $2.96 million in Q3 FY16.

Software as a service – During Q3 FY17, the Software as a service segment’s revenue increased 0.6% to $1.72 million from $1.71 million in the same period last year. For the reported quarter, the segment’s gross profit increased 13.5% to $1.43 million from $1.26 million in Q3 FY16.

Balance Sheet

As on October 31, 2017, Streamline’s cash and cash equivalents decreased 66.5% to $1.89 million from $5.65 million on January 31, 2017.

For the reported quarter, the Company’s net accounts receivables decreased 43.7% to $2.53 million from $4.49 million in Q4 FY16. For the reported quarter, the Company’s accounts payable decreased 27.7% to $807,778 from $1.12 million in Q4 FY16.

In the first nine months of 2017, the Company’s net cash provided by operating activities was negative $1.33 million compared to negative $1.24 million in the same period last year.

Stock Performance Snapshot

January 09, 2018 – At Tuesday’s closing bell, Streamline Health Solutions’ stock declined 6.18%, ending the trading session at $1.63.

Volume traded for the day: 53.92 thousand shares.

Stock performance in the last month – up 28.53%; previous six-month period – up 52.56%; and past twelve-month period – up 26.54%

After yesterday’s close, Streamline Health Solutions’ market cap was at $31.55 million.

The stock is part of the Technology sector, categorized under the Healthcare Information Services industry.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charter-holder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 485728